[at Motley Fool] – Both Biogen and Amgen are fighting competition with new drugs with blockbuster potential, but is one a better buy than the other?
Read more on this.
Biogen Idec Inc. (BIIB), with a current value of $56.39B, started the … [visit site to read more]
Similar posts:- Company Update – Amgen Inc. (NASDAQ:AMGN) – Better Buy: Biogen or Amgen?
- Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – BIIB December 6th Options Begin Trading
- Company Update: Biogen Idec Inc. (NASDAQ:BIIB) – Multiple Of 40x Earnings Gives Biogen Idec The Wobblies
